Benzinga | Aug 4, 2021 04:26PM EDT

Aerie Pharmaceuticals Q2 EPS $(0.84) Misses $(0.64) Estimate, Sales $27.20M Beat $26.28M Estimate

Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.64) by 31.25 percent. This is a 20 percent increase over losses of $(1.05) per share from the same period last year. The company reported quarterly sales of $27.20 million which beat the analyst consensus estimate of $26.28 million by 3.50 percent. This is a 50.83 percent increase over sales of $18.03 million the same period last year.